Can Fisher & Paykel Healthcare justify Nvidia-level premium amid tariff noise

Can Fisher & Paykel Healthcare justify Nvidia-level premium amid tariff noise
Fisher & Paykel Healthcare's Lewis Gradon addressed shareholders at the company's AGM. (Image: Jacques Steenkamp)
Stock & Trade
Most markets have them - market darlings which are treated as all but sacrosanct investments, whose shares are placed on a pedestal and priced far above multiples of their competitors. Overowned and overbought, with fundamentals that are rarely subject to strict scrutiny.Does Fisher & Paykel Healthcare fall into this camp?Get up to date fast. Join BusinessDesk's WhatsApp channel.Its shares trade 58 times trailing earnings – nosebleed territory – which puts it at a significant premium to other blue-chip medical technolog...

More Markets

NZ sharemarket continues momentum, Skellerup sees green
Markets Market Close

NZ sharemarket continues momentum, Skellerup sees green

 The Red Band gumboot-maker said it earned $54.5m after tax. 

Tom Raynel 21 Aug 2025
Xero board faces 'first strike' over CEO pay
Markets

Xero board faces 'first strike' over CEO pay

Xero investors fire warning shot at directors willing to pay big for talent.

Staff reporters 21 Aug 2025
Auckland airport dynamics returning to normal
Markets

Auckland airport dynamics returning to normal

Yields are improving for airlines operating into Auckland, but earnings look flat ahead. 

Pattrick Smellie 21 Aug 2025